AI/ ML will revolutionize medicine by making diagnosis and treatment more accessible and more effective.
FDA has regulated medical software by means of regulations and guidance for years, however, AI/ML programs fall outside the scope of these regulations and guidances.
This happens because FDA approves the final, validated version of the software. The point of AI/ML is to learn and update following deployment to improve performance. Thus the field version of the software is no longer the validated approved version.
We will discuss the current regulatory requirements, how they don’t control AI/ML adequately, and approaches FDA is considering for regulation in the near future. Your development program should conform to these concepts now because, with some modifications, they will probably become regulations.
Following a discussion of possible future regulations, we will discuss, based on recently approved De Novo applications, how to get your AI/ML program approved now. Necessary submission documentation will be explained.
This webinar is not a programming course but will explain the present and future regulatory requirements for AI/ML.
Managers, Supervisors, Directors, and Vice-Presidents in the areas of:
Managers, Supervisors, Directors, and Vice-Presidents in the areas of:
Edwin Waldbusser
Edwin Waldbusser, is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the areas of design control, risk analysis and software validation for the past 8 years. Mr. Waldbusser has a BS in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 Lead Auditor and a member of the Thomson Reuters Expert Witness network.
Female to Female Hostility @Workplace: All you Need to Know
The Importance of the first 5 seconds when presenting
How to Manage the Legal Landmine of the FMLA, ADA and Worke…
Managing Difficult Employee Conversations
How to Write Effective Audit Observations: The Principles f…
Managing Toxic & Other Employees Who Have Attitude Issues
2025 EEOC & Employers: Investigating Claims of Harassment …
Leadership: Strategic Planning and Decision Making
FDA Proposes Framework to Advance Credibility of AI Models
Reduce Stress in the Workplace: Effective Ways to Handle Co…
ChatGPT and Project Management: Leveraging AI for Project M…
Leverage AI-Powered Tools for Talent Acquisition: Best Prac…
6-Hour Virtual Seminar on Learning the Highlights of Excel …
With Mandatory Paid Leave Gaining Ground Is It Time To Do A…
Form W-9 Compliance: TIN Verification, B Notices, and Avoid…
How to Give Corrective Feedback: The CARE Model - Eliminati…
Tattoos, hijabs, piercings, and pink hair: The challenges …
Stress, Change And Team Resilience Through Humor: An Intera…
Elevate Your Workplace Wellness: 10 Critical Wellness Facto…
AML Regulatory Insight for Q1 2025: Implementing recent cha…
How to Write Right for Better Business Communication
Gossip-Free: Leadership Techniques to Quell Office Chatter
Improving Employee Engagement & Retention Through Stay Inte…
Transforming Anger And Conflict Into Collaborative Problem …